# Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol

> **NCT07308717** · PHASE4 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 1896 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** Modification to Pre-operative Order Set

## Key facts

- **NCT ID:** NCT07308717
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-16
- **Primary completion:** 2027-12-16
- **Final completion:** 2027-12-16
- **Target enrollment:** 1896 (ESTIMATED)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07308717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07308717, "Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT07308717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*